Publications by authors named "Juan Gomez-Rivas"

Claim this Profile
R
Re: EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer.
Inês Santiago, Juan Gómez Rivas

Eur Urol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robot-Assisted Salvage Prostatectomy: External Validation of the EAU Selection Criteria and Identification of the Optimal Candidate: A Junior ERUS/YAU Collaborative Study.
Mike Wenzel, Christoph Würnschimmel, Arjun Nathan, Marcio Covas Moschovas, Christian Wagner

Prostate· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severity of erectile dysfunction and premature ejaculation positively correlate with aggression levels in men: insights from a large population-representative study.
Mikolaj Przydacz, Giorgio I Russo, Nadir I Osman, Juan Gomez Rivas, Pawel Rajwa

Int J Impot Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate-Specific Antigen Response at Six Months Predicts Progression in Metastatic Hormone-Sensitive Prostate Cancer Treated With Apalutamide.
Christian Andrés Martínez Osorio, Raquel Sopeña Sutil, Antoni Vilaseca Cabo, Estefanía Linares Espinós, Miguel Ramírez Backhaus

Prostate· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate-specific Membrane Antigen Positron Emission Tomography Versus Conventional Imaging for Preoperative Staging High-risk Prostate Cancer Patients Undergoing Surgery for cN0M0 Disease: An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study.
Lorenzo Bianchi, Matteo Droghetti, Calogero Catanzaro, Massimo Valerio, Quentin Novello

Eur Urol Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RESECT: A Randomised Controlled Trial of Audit and Feedback in Non-muscle-invasive Bladder Cancer Surgery.
Kevin Gallagher, Steven MacLennan, Nikita Bhatt, Keiran Clement, Eleanor Zimmermann

Eur Urol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Observational Health Data Analysis of the Cardiovascular Adverse Events of Systemic Treatment in Patients with Metastatic Hormone-sensitive Prostate Cancer: Big Data Analytics Using the PIONEER Platform.
Pawel Rajwa, Angelika Borkowetz, Thomas Abbott, Andrea Alberti, Katharina Beyer

Eur Urol Focus· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Evidence on Baseline Characteristics and Treatment in Metastatic Hormone-sensitive Prostate Cancer: Findings from the PIONEER 2.0 Big Data Investigation Group.
Juan Gómez Rivas, Pia Kraft, Susan Evans-Axelsson, Ayman Hijazy, Katharina Beyer

Eur Urol Open Sci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re: Darolutamide in Combination with Androgen-deprivation Therapy in Patients with Metastatic Hormone-sensitive Prostate Cancer from the Phase III ARANOTE Trial.
Juan Gómez Rivas, Jesús Moreno Sierra

Eur Urol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncological Outcomes After Robotic Salvage Radical Prostatectomy in Patients Primarily Treated With Focal Versus Radiation Therapy: A Junior ERUS/YAU Collaborative Study.
Mike Wenzel, Arjun Nathan, Marcio Covas Moschovas, Christian Wagner, Giorgio Calleris

Prostate· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Trajectories in Metastatic Hormone-sensitive Prostate Cancer: A PIONEER+ Big Data Analysis.
Rossella Nicoletti, Alex Qinyang Liu, Susan Evans-Axelsson, Asieh Golozar, Katharina Beyer

Eur Urol Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re: [Lu]Lu-PSMA-617 plus Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer (ENZA-p): An Open-label, Multicentre, Randomised, Phase 2 Trial.
Juan Gómez Rivas, Jesús Moreno Sierra

Eur Urol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
oDigital pathology biomarkers for guiding radiotherapy-based treatment concepts in prostate cancer - a systematic review and expert consensus.
Constantinos Zamboglou, William De Doncker, Andreas Thomas Christoforou, Stefano Arcangeli, Alejandro Berlin

Radiother Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Research protocol for the evaluation of TriNetra™ prostate: a circulating tumor cell-based diagnostic tool for prostate cancer.
Juan Gómez Rivas, Paula Mata Deniz, Arianna Pischetola, Moisés Rodríguez Socarrás, Vanesa Cuadros Rivera

Int J Surg Protoc· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond PSA: The Future of Prostate Cancer Diagnosis Using Artificial Intelligence, Novel Biomarkers, and Advanced Imagery.
Moncef Al Barajraji, Mathieu Coscarella, Ilyas Svistakov, Helena Flôres Soares da Silva, Paula Mata Déniz

Life (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of postoperative practices and discharge recommendations after radical prostatectomy.
Bárbara Vieira Lima Aguiar Melão, Melissa Assel, Maria Pere, Sunny Nalavenkata, Karim A Touijer

Urol Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the Reporting and Incidence of Prostate Cancer Unconventional Histologies in Tertiary Referral Institutions: An Under-reported but Exploding Phenomenon?
Giancarlo Marra, Geert J L H van Leenders, Guglielmo David, Marco Oderda, Kirsti Aas

Eur Urol Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing Standardised Training and Education: The Vision of the European Association of Urology Led by the European School of Urology.
Bhaskar K Somani, Carlotta Nedbal, Tiago Ribeiro de Oliveira, Chandra Shekhar Biyani, Domenico Veneziano

Eur Urol Open Sci· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GPT-4 generates accurate and readable patient education materials aligned with current oncological guidelines: A randomized assessment.
Severin Rodler, Francesco Cei, Conner Ganjavi, Enrico Checcucci, Pieter De Backer

PLoS One· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary Outcomes of Minimally Invasive Treatments for Prostate Cancer-A Systematic Review by Young Academic Urologists' Urotechnology Working Group.
Mark Taratkin, Alexander Androsov, Andrey Morozov, Camilla Azilgareeva, Juan Gomez Rivas

J Endourol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sexual function outcomes in men undergoing minimal invasive ablative techniques for prostate cancer: a ESRU/YAU urotech systematic review and pooled analysis.
Federico Piramide, Alessandro Veccia, Lazaros Tzelves, Sven Nikles, Luis E Ortega Polledo

Minerva Urol Nephrol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of lymph node dissection on oncological outcomes in contemporary robotic salvage radical prostatectomy patients: a junior ERUS/YAU collaborative study.
Mike Wenzel, Christoph Würnschimmel, Marcio Covas Moschovas, Arjun Nathan, Christian Wagner

World J Urol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen Receptor Pathway Inhibitor Monotherapy in Prostate Cancer: Safety, Oncologic Outcomes, and Quality of Life-A Systematic Review and Meta-analysis.
Tamás Fazekas, Marcin Miszczyk, Alexander Giesen, Tamás Kói, Fabio Zattoni

Eur Urol Focus· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET) in Initial Staging of Prostate Cancer Patients: The Beginning of a New Era.
Juan Gómez Rivas, Irene de la Parra, Sarelis Infante, Laura Ibañez, Beatriz Gutierrez Hidalgo

Medicina (Kaunas)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Rising stars in urologic oncology: 2023.
Juan Gomez Rivas

Front Urol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis